Chiome Bioscience

Chiome Bioscience Inc. is engaged in the discovery and development of antibody drugs, focusing on early-stage research and initial clinical trials. The company operates through two reportable segments: the Drug Discovery segment and the Drug Development Support segment. The Drug Discovery segment conducts antibody research and development targeting diseases with high unmet medical needs, aiming to generate revenue through licensing agreements, upfront payments, milestone payments, and royalties. The Drug Development Support segment provides services such as antibody production and related support using proprietary antibody technology to meet the needs of pharmaceutical and diagnostic companies as well as academic institutions.